Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

Alembic has a cumulative total of 218 ANDA approvals (191 final approvals and 27 tentative approvals) from USFDA, it added.

The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...

Alembic Pharmaceuticals Limited announced today it has received final approval from the US Food & Drug Administration (USFDA) ...

HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47 ...

These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering a generic alternative to ...

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

Camphor, a traditional ingredient in South Asian desserts, offers a unique cooling flavor and cultural significance. While ...

The US Food and Drug Administration (FDA) has now proposed an order to remove oral phenylephrine from every single cold, ...